ArticleThe American journal of pathology2024

Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia.

Meagan Goates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.